Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 187
Selected: 0
NCT IDTitle
NCT04686188Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer
NCT073912155G-PEARL: Paxalisib in Malignant Brain Tumours
NCT01000129Adaptive Planning in Bladder Cancer
NCT02757651KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response
NCT02978014A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy
NCT03727698Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment
NCT02780375Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects
NCT03177187Combination Study of AZD5069 and Enzalutamide.
NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
NCT03307148Stromal TARgeting for PAncreatic Cancer (STAR_PAC)
NCT04117594Whole Body Magnetic Resonance Imaging Study
NCT01331525The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer
NCT02388230Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound Techniques
NCT011246823-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder
NCT066302605G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
NCT06470685Prophylactic Prostatectomy for Prostate Cancer (PPPC)
NCT05432739Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study
NCT01505829Diffusion-weighted Imaging Study in Cancer of the Ovary
NCT04065269ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss
NCT00997464An Exploration of Genetic Testing for Prostate Cancer Susceptibility
NCT03621332HRQoL in Advanced Soft Tissue Sarcoma Patients Treated With Chemotherapy.
NCT07002320Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
NCT02705846Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
NCT02437227Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833
NCT07529418The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study
NCT01726374Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours
NCT01737242UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies
NCT01993979A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)
NCT02587455Pembrolizumab and Palliative Radiotherapy in Lung
NCT05097274The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.
NCT00022191Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
NCT01685190A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer
NCT05782361POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
NCT02389842PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib
NCT04901468A-EYE: A Mixed Quantitative and Qualitative Study to Develop and Evaluate the Application of Artificial Intelligence (AI) Methods Using Retinal Imaging for the Identification of Adverse Retinal Changes Associated With Cancer Therapies.
NCT02388308Evaluation of Clarity Ultrasound Guidance for Prostate Therapy
NCT07432932Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
NCT04270799Lung Nodule Imaging Biobank for Radiomics and AI Research
NCT02973828PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy
NCT02360345Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly
NCT06357416The Man Van Project
NCT066322365G-EMERALD: Amivantamab in Malignant Brain Tumours
NCT00028756Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
NCT02688257Assessing Treatment Response in Breast Cancer With Functional Imaging
NCT03809377Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)
NCT03934164Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO
NCT00867347Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer
NCT04584853PreOperative Endocrine Therapy for Individualised Care With Abemaciclib
NCT02560636Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer
NCT01006564Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer